Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and Associated Products

This agreement is for the supply of Insulin Pumps, Continuous Glucose Monitoring (CGM) devices, Applications or software to enable the function of Closed Loop Insulin Delivery Systems and also for the dedicated consumables and accessories for the products listed above.

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £15,000,000 - £20,000,000 in the first year year of this agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated total value over the 4 year agreement is approximately £75,000,000 to £100,000,000.

This lot is for Standalone Insulin Pumps and also Tethered Insulin Pumps, Patch Insulin Pumps, Tethered Pump with Integrated Continuous Glucose Monitor, Patch Pumps with Integrated Continuous Glucose Monitor, Tethered Pump with Integrated Continuous Glucose Monitor and Algorithm. This Lot also includes, but is not limited to;

Insulin subcutaneous infusion set

Tubes

Cannula’s

Needle cartridges

Handsets

Insertion Devices

Adaptors

Batteries

Carry Cases

Belts

Remotes

Sensors

Finger Prickers

Battery caps

Resevoirs

USB Adapters

Clips

Luer Locks

Dressings

Pouches

Service packs

Any other option or accessory used with or to configure the pumps Additional information: Anticipated expenditure will be circa £18,000,000 for the two years of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 48 month term (if extended) the anticipated value is circa £36,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.